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Abstract.
Impact of EEG biofeedback on event-related potentials (ERPs) in attention-deficit hyperactivity (ADHD) children.
Introduction: ADHD is one of the most widely spread condition of school aged children affecting  5% of children 
of this age. Diagnosis of ADHD increased and the rate had risen to 3.4% and it continues to rise. The core clinical 
signs of ADHD are inattention, restlessness and impulsivity. It is known that there are a numerous neurometric 
tools widely used for assessment of children with ADHD. According to various authors direct measures of 
attention are of two types:
1. Recording the alpha rhythm on the EEG and  event-related potentials (ERP);
2. Tests of reaction time, continuous performance tests, paired associated learning, and tests of memorization;
The second one is evidence-based. As for the first one it is known that ERPs especially of those with later 
response reflect the process of mental effortfullness to select the appropriate behavior and accomplish decision 
making during the action of target stimulus. Thus selection of action as well as decision making is the most 
important points affected in ADHD children. Besides in recent years EEG biofeedback ( Neurofeedback) have 
become the evidence-based in the treatment of ADHD. Unfortunately the effectiveness of this approach on 
ERPs parameters is still unknown. Thus we aimed to study the changes of ERPs after neurofeedback therapy. 
Methods: We have examined  16 children with ADHD before- and after  3- sessions of neurofeedback therapy 
and 23 without treatment.  Results: We have observed statistically significant improvement of parameters of 
later response like P300 in treated children compared with untreated ones whereas the treatment was non 
effective for earlier components of ERPs. Conclusions: Neurofeedback can affect on the process of selection of 
action and decision making by means of changing of P300 parameters in ADHDchildren. 
Introduction: ADHD is one of the most widely spread condition of school aged children affecting  5% of children 
of this age [1]. Diagnosis of ADHD increased and the rate had risen to 3.4% and it continues to rise [2]. The core 
clinical signs of ADHD are inattention, restlessness and impulsivity. It is known that there are a numerous 
neurometric tools widely used for assessment of children with ADHD. According to various authors direct 
measures of attention are of two types [3]: 
3. Recording the alpha rhythm on the EEG and  event-related potentials (ERP);
4. Tests of reaction time, continuous performance tests, paired associated learning, and tests of memorization;
The last one is clinically proved and used in routine practice but as for the first one its validity is still ambiguous 
and has limited application in clinical practice especially of long latency event-related potentials (ERP). ERP 
studies is extremely important as it reflects multitude of cognitive factors such as attention, memory and language. 
Thus assessment of its components is very valuable in disorders accompanied with attention impairment including 
ADHD.  The use of P3 for clinical assessment of various neurological diseases is recommended by International 
Federation of clinical neurophysiology [4]. ERP studies in ADHD started in 1970s with the work of Satterfield 
and his group [5]. 
ERP is recorded under certain conditions like using of certain modality stimulus. It is known that its latency 
increases as a categorization of the stimulus becomes more difficult [6], [7], [8] while others have reported that 
ERP latency remains unaffected by task difficulty [9].   The simplest way for auditory ERP to be recorded is 
during performing auditory oddball paradigm [10]. The core feature is to give series of stimuli with randomized
consequence. These stimuli used for recording of ERP are divided into two ways: non- target and target which has 
to be recognized by patient. The ERP response recorded during recognition of relatively rare target stimulus differs 
from others by morphology as it appears with positive wave within latency range of 300 ms. This wave is called 
P3. 
The response on target stimulus can be divided into two ways: 
1. Earlier response P1-N1-P2 connected to simple auditory stimulus. 
2. Relatively later N2-P3-N3-complex related to cognition like recognition and differentiation of stimulus  
and  decision making which patient can express by pushing the button when hearing and recognizing target 
stimulus. 
The earlier component like N1 - a first  discernible peak is a negativity around 80 ms with a frontocentral 
maximum present for both rare and frequent tones [4].  It generally thought to represent the initial extraction of 
information from sensory analysis of the stimulus [11] and  represents the correct recognition of stimulus [12]. 
The most significant component of later response is P3. It is proposed that amplitude and latency of P3 reflect the 
extent and timing of a distribution-specific cognitive process, while scalp distribution is indicative of which 
cognitive process is activated during the performance of a task [13].
The P3 reflects multiple cognitive processes, specifically attentional resource allocation [14]..P3 amplitude is 
thought to be a reflection of effortfulness of the stimulus response and the intensity of processing  whereas P3 
latency is taken as a reflection of the speed of information processing [15]. The assessment of P3 is important in 
ADHD children for several reasons: The first it is known that most important aspect of executive functioning 
frequently affected in ADHD children  is engagement operation [10]. This process from neurophysiological point 
of view is associated with the activation of cortical and subcortical structures that are involved in execution of the 
selected action which is disturbed in ADHD children. From psychological, functional point of view the 
engagement operation is associated with combining all brain resources for the action to be accomplished [10]. This 
operation is manifested in the P3 components. And the second according to Desmedt and Debecker’s hypothesis 
the occurrence of P3 corresponds to the termination of the decision-making process which is taking place during 
the categorization of the target stimulus [16]. 
There are several studies concerning clinical values of ERP in children with ADHD. In spite of enormous studies 
in this field the unified consensus about morphology and clinical value of P3 in ADHD children is still absent. 
According to various authors P3 in ADHD does not differ from that of control group  [17]  whereas others detected 
significant changes in amplitude and latency of P3 in ADHD vs controls   [10], [18].   According to Alexander and 
colleagues [19] P3 can serve as a valid marker of attention disorders in ADHD and predictor of pharmacological 
treatment [20], [21], [22]. 
As for non pharmacological intervention less is known about impact of EEG Biofeedback (neurofeedback-NF) on 
P3 characteristics although NF becomes evidence based treatment option for ADHD in recent years. According to 
evidence-based practice in biofeedback and neurofeedback recommended by international society for mind-body 
research, health care and education,  the efficacy of NF in ADHD has satisfied the upper level of efficacy ( level 4 
efficacy) [23].. Such popularity of NF can be explained by the fact that stimulants frequently used for the 
treatment of ADHD can cause various side effects including growth suppression. In addition, estimates indicate 
that as many as 30% of children with ADHD either do not respond to stimulant treatment or cannot tolerate the 
treatment secondary to side effects. This has lead to the consideration of treatment with both nonstimulant 
medications as well as alternative therapies, including diet, iron supplementation and NF [24]. Only several papers 
are devoted to impact of NF on ERP measures [10], [25].  According to Wangler and colleagues [25], the decrease 
of P3 latency was observed after NF therapy but according to these authors these evidence is less valid as 18 units 
for a single NF protocol might have been to small to obtain specific ERP effects. Besides this study is not 
consistent because of absence of comparative analysis as it did not include non - treated ADHD children as a 
control group. 
Thus assessment of ERP parameters before- and after NF treatment is extremely important in ADHD children. 
Materials and methods: We prospectively studied 39 children with ADHD of combined subtype (ADHDcom) 
without any kind of pharmacological treatment. Age range10-12 years.  All  children met the diagnostic criteria for 
ADHDcom according to the DSM-IV (American Academy of Pediatrics: Clinical Practice Guideline: Diagnosis 
and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder. Pediatrics 2000; 105 (5):  1158-1170). 
ADHD was diagnosed by board certified  experienced neurologist and a paediatric neurologist based on the child’s 
detailed neurological and neuropsychological examination and a detailed caregiver interview using Conners parent 
rating scale [26]. This group was divided into two subgroups: The first ADHDcom-1 (16 children) were children 
where NF treatment was carried out and the second subgroup of ADHDcom-2 (23 children) were non treated 
children. Such distribution of patients can be explained by the fact that P3 [27] as well as N1 [28] can exhibit 
habituation by repetition after certain time interval.  
We obtained informed written consent from parents or guardians of all children. The study protocol was approved 
by the Biomedical Research Ethic Committee in Tbilisi State Medical  University. 
A neuropsychological assessment was conducted in all group of children, including IQ testing by the Wechsler 
Intelligence Scale for Children-Revised (WISC-R). The inclusion criteria were  IQ>70. All other children assessed 
were determined to be intellectually disabled  and were excluded from study. 
ERP was also carried out in both group of children .The parameters of ERP assessed were polarity (positive or 
negative), timing (latency) and amplitude. Omission (misses) and commission (false alarms) errors were also 
investigated as they are thought to index impulsivity [29]. EEG was recorded  using with silver plated electrodes 
placed at  area according to the international 10-20 system. We have chosen only Cz-A1 derivation for the analysis
for two reasons:
1. It is known that amplitude of N1 as well as P3 at target stimuli is the largest in the midline [4], [18].  In 
order to avoid interregional effect frequently observed in ERP studies as it was out of scope of our study. 
Cap electrodes were referenced to linked ears. Impedance was kept below 5 kµ for the cap electrodes. The 
subject was grounded by the cap ground electrodes located midway between Fpz and Fz. EEG was amplified 
20 000 times with a bandpass down 3dB at 0.1 and 25 Hz and was sampled through a 12-bit analog-to-digital 
converter at 200 Hz. In the laboratory each child was familiarized with the testing equipment and procedure. 
All tasks were completed in a sound-attenuated air-conditioned room. Seated on a comfortable chair children 
were presented with auditory stimuli binaurally through headphones.  Conditions of stimulations were:
 Stimulation-binaural
 Duration of stimulus-50ms.
 Intensiveness - 80Db
 Interstimulus period-1 second
 Tone frequency:
- For target stimulus-2000Hz, reliability 20-30%,
- For non-target stimulus-1000Hz, reliability 70-80%.
Non-target and target stimuli were given in an absolutely randomized way 1-2 target stimulus appears after 
each 5 non-target stimuli. 
  For more refinement of study we choose only two components of ERP:  N1 as an earlier electrical correlate of 
cortical activity reflecting correct choice of task and P3 as a later one reflecting complex act of executive functions 
including attention.  
NF was carried out in ADHDcom-1 children according to protocol previously developed by Lubar [30] It was 
conducted over a period of 6 weeks (30 sessions, five training per week). Training was divided into two phases (15 
sessions in each phase): in the first phase children were trained to enhance the amplitude of SMR (12-15) Hz and 
decrease the amplitude of theta activity (4-7Hz); In the second phase beta/theta training was used which required 
children to decrease the amplitude of theta waves (4-7Hz) and reward their beta 1 waves (15-18 Hz). During the 
first phase EEG was recorded from Cz, with reference placed on the left earlobe and ground electrode on the right 
earlobe. During the second phase EEG was recorded from Fz-Pz derivations with the same localization of the 
reference and ground electrodes. It is known that SMR enhancement reduces hyperactivity problems. As for 
beta/theta training the basic assumption guiding this approach is that suppressing theta activity diminishes attention 
problems [31]..Each session was subdivided into 2 min periods (that were gradually increased up to 10 min). 
During the training sessions children were attempting to work with puzzles on the screen, solve mathematical 
problems and maintain a state relaxation by watching cartoons. 
Data were analyzed by different descriptive and inferential statistical methods using SPSS 10.0. The 2
groups × 2 conditions repeated measures ANOVA was used to determine the effect of treatment on ERPs for the 
study groups. The correlation analysis was made by the Spearman’s rho and the Pearson correlations. The 
independent-sample t test was used to make the between group comparisons. The nonparametric Mann Whitney U 
test was used to make between group comparisons for independent samples. The nonparametric Mann Whitney U 
test was used to compare ADHD groups with and without treatment.
Results:
Case-control study of assessing ERPs was performed by forming groups of ADHD children without treatment and 
ADHD children with treatment. Table 1 presents the percentage distribution of study groups, mean age and means 
of latency N1, amplitude N1, latency P3, amplitude P3, of omission and commission error rates before and after 
treatment (Figure 1, Figure 2).   
Table 1. The percentage distribution of the study groups, mean age and means of latency, amplitude, and of error rates before and after 
treatment.
Group
N (%)
Age
M (σ; 
min-
max)
Latency N1 Amplitude N1 Latency P3 Amplitude P3 Omission errors Commission errors
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ADHD 
with
treatment
16 
(41 %)
10.63 
(.81; 10-
12) 
115.19 
(15.93; 
83-
133)
113.81 
(16.19; 
81-132)
5.31 
(2.7; 1-
10)
5.38 
(2.68; 2-
10)
465.94 
(33.73; 
401-
523)
417.31 
(22.51; 
357-441)
6.87 
(2.03; 3-
10)
9.81 
(1.87; 
7-13)
5.13 (1.59; 
2-8)
2.38 
(.89; 1-
4)
4.5 (2.31; 
1-8)
.88 
(.89; 0-
3)
ADHD 
without 
treatment 
23 
(59 %)
10.57 
(.73; 10-
12)
116.78 
(15.22; 
85-
135)
115.61 
(16.68; 
83-141)
3.61 
(1.75; 
1-7)
4.13 
(1.82; 1-
8)
445.26 
(51.26; 
354-
501)
420.13 
(45.4; 
343-487)
6.39 
(1.67; 3-
9)
7.3 
(1.69; 
3-10)
5.39 (2.13; 
1-9)
4.7 
(1.79; 2-
7)
4.3 (1.61; 
2-8)
4.87 
(2.91; 
0-9)
Figure 1. The percentage distribution and the mean age of the study groups.
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Figure 2. The mean performance of latency, amplitude, and of error rates before and after treatment for study groups.
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Results: 
The mean amplitude N1 before treatment was significantly higher t(23.676)=2.219, p<.036 for the ADHD 
treated group (mean=5.31, SD=2.7) compared to the ADHD non treated group (mean=3.61, SD=1.75) (Figure 2). 
The mean amplitude P3 after treatment was significantly higher t(47)=4.376, p<.0001 for the ADHD treated group 
(mean=9.81, SD=1.87) compared to the ADHD non treated group (mean=7.3, SD=1.69). The mean omission
errors rate after treatment was significantly higher t(33.979)=-5.338, p<.0001for the ADHD non treated group 
(mean=4.7, SD=1.79) compared to the ADHD treated group (mean=2.38, SD=.89). The mean commission errors
rate after treatment was significantly higher t(27.518)=-6.18, p<.0001for the ADHD non treated group 
(mean=4.87, SD=2.91) compared to the ADHD treated group (mean=.88, SD=.89). The same results were 
obtained for these variables using the nonparametric Mann Whitney U test.
The Wilcoxon matched-pairs, signed rank test for the group of ADHD children without treatment showed 
that the difference between the median latency N1 before treatment (M=116.78, SD=15.22) and median latency N1
after time interval (M=115.61, SD=16.68) was significant beyond .05 level: Z=-2.2, p<.028. The median latency 
N1 at the first time was significantly higher than median latency N1 after time interval. The difference between the 
median amplitude N1 before treatment (M=3.61, SD=1.75) and median amplitude N1 after time interval (M=4.13, 
SD=1.82) was significant beyond .05 level: Z=-2.546, p<.011. The median latency N1 after time interval was 
significantly higher than median amplitude N1 before treatment. The difference between the median latency P3 at 
the first time (M=445.26, SD=51.26) and median latency P3 after time interval (M=420.13, SD=45.4) was 
significant beyond .001 level: Z=-4.168, p<.0001. The median latency P3 at the first time was significantly higher 
than median latency P3 after time inetraval. The difference between the median amplitude P3 at the first time 
(M=6.39, SD=1.67) and median amplitude P3 after time interval (M=7.3, SD=1.69) was significant beyond .001 
level: Z=-3.493, p<.0001. The median amplitude P3 after time interval was significantly higher than median 
amplitude P3 at the first time. The difference between the median omission error rate at the first time (M=5.39, 
SD=2.13) and median omission error rate after time interval (M=4.7, SD=1.79) was significant beyond .05 level: 
Z=-2.054, p<.04. The median omission error rate at the first time was significantly higher than median omission 
error rate after time interval.
The Wilcoxon matched-pairs, signed rank test for the group of ADHD children with treatment showed that 
the difference between the median latency N1 before treatment (M=115.19, SD=15.93) and median latency N1 after 
treatment (M=113.81, SD=16.19) was significant at one tail Z=-1.898, p<.058. The median latency N1 before 
treatment was significantly higher than median latency N1 after treatment. The difference between the median 
latency P3 before treatment (M=465.94, SD=33.73) and median latency P3 after treatment (M=417.31, SD=22.51) 
was significant beyond .001 level: Z=-3.517, p<.0001. The median latency P3 before treatment was significantly 
higher than median latency P3 after treatment. The difference between the median amplitude P3 before treatment 
(M=6.87, SD=2.03) and median amplitude P3 after treatment (M=9.81, SD=1.87) was significant beyond .001 
level: Z=-3.546, p<.0001. The median amplitude P3 after treatment was significantly higher than median amplitude
P3 before treatment. The difference between the median omission error rate before treatment (M=5.13, SD=1.59) 
and median omission error rate after treatment (M=2.38, SD=.89) was significant beyond .001 level: Z=-3.539, 
p<.0001. The median omission error rate before treatment was significantly higher than median omission error rate 
after treatment. The difference between the median commission error rate before treatment (M=4.5, SD=2.31) and 
median commission error rate after treatment (M=.88, SD=.89) was significant beyond .001 level: Z=-3.426, 
p<.001. The median commission error rate before treatment was significantly higher than median commission 
error rate after treatment.
To determine the effect of treatment on latency N1, the data from the latency N1 before treatment and latency 
N1 after treatment were entered separately into a 2 (group) × 2 (condition – latency N1 before treatment vs. latency 
N1 after treatment) ANOVA. The ANOVA showed a significant effect of condition F(1,37)=6.282, MSE=4.879, 
p<.017, partial eta squared =.145 represents a large effect size. The effects of group (F<1) and interaction between 
group and condition (F<1) were not significant. The effect of age was significant F(1,36)=182.252, MSE=86, 
p<.0001, partial eta squared =.835 represents a large effect size, but the interaction between age and condition 
wasn’t significant (F<1). The taking of age as covariate change relationships between the study variables and the 
effect of condition became not significant.
To determine the effect of treatment on amplitude N1, the data from the amplitude N1 before treatment and 
amplitude N1 after treatment were entered separately into a 2 (group) × 2 (condition – amplitude N1 before 
treatment vs. amplitude N1 after treatment) ANOVA. The ANOVA showed a significant effect of condition 
F(1,37)=4.829, MSE=.333, p<.034, partial eta squared =.145 represents a large effect size, and of group 
F(1,37)=4.399, MSE=9.323, p<.043, partial eta squared =.106 represents a close to medium effect size. The effects 
of interaction between group and condition was significant at one tail F(1,37)=2.984, MSE=.333, p<.092. The 
effect of age was significant F(1,36)=23.655, MSE=5.782, p<.0001, partial eta squared =.397 represents a large 
effect size, but the interaction between age and condition wasn’t significant (F<1) (Figure 3). The taking of age as 
covariate didn’t change relationships between the study variables.
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Figure 3. The means of amplitude N1 before and after treatment for study groups.
To determine the effect of treatment on latency P3, the data from the latency P3 before treatment and latency 
P3 after treatment were entered separately into a 2 (group) × 2 (condition – latency P3 before treatment vs. latency 
P3 after treatment) ANOVA. The ANOVA showed a significant effects of condition F(1,37)=223.69, 
MSE=114.735, p<.0001, partial eta squared =.858 represents a large effect size and of interaction between group 
and condition F(1,37)=22.698, MSE=114.735, p<.0001, partial eta squared =.38 represents a large effect size. The 
effect of group was not significant (F<1). The ANOVA showed a significant effects effect of age F(1,36)=40.62, 
MSE=1612.812, p<.0001, partial eta squared =.53 represents a large effect size, and interaction between age and 
condition F(1,36)=26.96, MSE=67.427, p<.0001, partial eta squared =.428 represents a large effect size (Figure 4). 
The taking of age as covariate didn’t change relationships between the study variables.
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Figure 4. The means of latency P3 before and after treatment for study groups.
To determine the effect of treatment on amplitude P3, the data from the amplitude P3 before treatment and 
amplitude P3 after treatment were entered separately into a 2 (group) × 2 (condition – amplitude P3 before 
treatment vs. amplitude P3 after treatment) ANOVA. The ANOVA showed a significant effects of condition 
F(1,37)=157.263, MSE=.443, p<.0001, partial eta squared =.81 represents a large effect size; of group 
F(1,37)=7.07, MSE=6.008, p<.012, partial eta squared =.16 represents a large effect size, and of interaction 
between group and condition F(1,37)=44.044, MSE=.443, p<.0001, partial eta squared =.543 represents a large 
effect size. The effect of age was significant F(1,36)=7.721, MSE=5.085, p<.009, partial eta squared =.177 
represents a large effect size but the interaction between age and condition wasn’t significant (F<1) (Figure 5). 
After taking of age as covariate the effect of condition became not significant but didn’t change other relationships 
between the study variables.
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Figure 5. The means of amplitude P3 before and after treatment for study groups.
To determine the effect of treatment on omission error rate, the data from the omission error rate before 
treatment and omission error rate after treatment were entered separately into a 2 (group) × 2 (condition – omission 
error rate before treatment vs. omission error rate after treatment) ANOVA. The ANOVA showed a significant 
effects of condition F(1,37)=54.634, MSE=1.025, p<.0001, partial eta squared =.596 represents a large effect size; 
of group F(1,37)=6.422, MSE=4.917, p<.016, partial eta squared =.148 represents a large effect size and of 
interaction between group and condition F(1,37)=19.421, MSE=1.025, p<.0001, partial eta squared =.344 
represents a large effect size. The ANOVA showed a significant effects effect of age F(1,36)=61.727, MSE=1.861, 
p<.0001, partial eta squared =.632 represents a large effect size, and interaction between age and condition 
F(1,36)=9.672, MSE=.831, p<.004, partial eta squared =.212 represents a large effect size (Figure 6). The taking of 
age as covariate didn’t change relationships between the study variables.
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Figure 6. The means of omission error rate before and after treatment for study groups.
To determine the effect of treatment on commission error rate, the data from the commission error rate before 
treatment and commission error rate after treatment were entered separately into a 2 (group) × 2 (condition –
commission error rate before treatment vs. commission error rate after treatment) ANOVA. The ANOVA showed 
a significant effects of condition F(1,37)=20.004, MSE=2.208, p<.0001, partial eta squared =.351 represents a large 
effect size; of group F(1,37)=9.937, MSE=6.852, p<.003, partial eta squared =.212 represents a large effect size, 
and of interaction between group and condition F(1,37)=37.515, MSE=2.208, p<.0001, partial eta squared =.503 
represents a large effect size. The effects of age (F<1) and interaction between age and condition were not 
significant (F<1) (Figure 7). After taking of age as covariate the effect of condition became not significant but
didn’t change other relationships between the study variables.
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Figure 7. The means of commission error rate before and after treatment for study groups.
To determine the effect of treatment on latency, the data from the latency N1 before treatment and latency P3
before treatment were entered separately into a 2 (group) × 2 (condition – latency N1 before treatment vs. latency 
P3 before treatment) ANOVA. The ANOVA showed a significant effect of condition F(1,37)=3712.44, 
MSE=586.307, p<.0001, partial eta squared =.99 represents a large effect size. The effect of group was not 
significant. The effect of interaction between group and condition was significant at one tail F(1,37)=3.992, 
MSE=586.307, p<.053. The effects of age F(1,36)=90.941, MSE=489.096, p<.0001, partial eta squared =.716 
represents a large effect size, and interaction between age and condition F(1,36)=19.768, MSE=338.991, p<.0001,
partial eta squared =.354 represents a large effect size, were significant (Figure 8). The taking of age as covariate 
change relationships between the study variables and revealed the significant effect of interaction between group 
and condition F(1,36)=6.902, MSE=388.991, p<.013, partial eta squared =.161 represents a large effect size.
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Figure 8. The means of latency N1 and P3 before treatment for study groups.
To determine the effect of treatment on amplitude, the data from the amplitude N1 before treatment and 
amplitude P3 before treatment were entered separately into a 2 (group) × 2 (condition – amplitude N1 before 
treatment vs. amplitude P3 before treatment) ANOVA. The ANOVA showed a significant effects of condition 
F(1,37)=53.222, MSE=1.674, p<.0001, partial eta squared =.59 represents a large effect size, and interaction 
between group and condition F(1,37)=4.196, MSE=1.674, p<.048, partial eta squared =.102 represents a medium 
effect size. The effect of group was significant at one tail F(1,37)=6.438, MSE=3.507, p<.069. The effect of age 
was significant F(1,36)=18.78, MSE=4.349, p<.0001, partial eta squared =.343 represents a large effect size but the 
interaction between age and condition was significant at one tail F(1,36)=3.242, MSE=1.578, p<.08 (Figure 9). The 
taking of age as covariate didn’t change relationships between the study variables.
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Figure 9. The means of amplitude N1 and P3 before treatment for study groups.
To determine the effect of treatment on latency, the data from the latency N1 after treatment and latency P3
after treatment were entered separately into a 2 (group) × 2 (condition – latency N1 after treatment vs. latency P3
after treatment) ANOVA. The ANOVA showed a significant effect of condition F(1,37)=3935.793, MSE=443.159, 
p<.0001, partial eta squared =.991 represents a large effect size. The effects of group and interaction between 
group and condition were not significant. The effect of age F(1,36)=59.26, MSE=489.116, p<.0001, partial eta 
squared =.622 represents a large effect size, and interaction between age and condition F(1,36)=4.592, 
MSE=403.941, p<.039, partial eta squared =.113 represents a large effect size, were significant. The taking of age 
as covariate didn’t change relationships between the study variables.
To determine the effect of treatment on amplitude, the data from the amplitude N1 after treatment and 
amplitude P3 after treatment were entered separately into a 2 (group) × 2 (condition – amplitude N1 after treatment 
vs. amplitude P3 after treatment) ANOVA. The ANOVA showed a significant effects of condition 
F(1,37)=138.457, MSE=1.97, p<.0001, partial eta squared =.789 represents a large effect size, and group 
F(1,37)=11.078, MSE=6.026, p<.002, partial eta squared =.23 represents a large effect size. The effect of 
interaction between group and condition was significant at one tail F(1,37)=3.877, MSE=1.97, p<.056. The effect 
of age F(1,36)=20.005, MSE=3.981, p<.0001, partial eta squared =.357 represents a large effect size, and
interaction between age and condition F(1,36)=5.747, MSE=1.746, p<.022, partial eta squared =.138 represents a 
large effect size, were significant (Figure 10). The taking of age as covariate change relationships between the 
study variables and revealed the significant effect of interaction between group and condition F(1,36)=4.775, 
MSE=1.746, p<.035, partial eta squared =.117 represents a large effect size.
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Figure 10. The means of amplitude N1 and P3 after treatment for study groups.
The correlation analysis didn’t show significant relationships between commission error rates and the study 
variables. The significant correlations were not found between omission and commission error rates. The 
correlation between the omission error rate before treatment and commission error rate before treatment was 
significant at one tail rs=.45, p<.083 for the group of ADHD children with treatment but not for the group of 
ADHD children without treatment. The significant correlation was found between the commission error rates 
before and after treatment r=.36, p<.025 (for the group of ADHD children with treatment correlation was 
significant at one tail rs=.46, p<.075; for the group of ADHD children without treatment significant correlation was 
found rs=.71, p<.0001).
The high significant correlations were found between age and latency N1 before treatment r=-.92, p<.0001, 
amplitude N1 before treatment r=.57, p<.0001, latency N1 after treatment r=-.90, p<.0001, amplitude N1 after 
treatment r=.62, p<.0001, latency P3 before treatment r=-.74, p<.0001, amplitude P3 before treatment r=.43, p<.006, 
latency P3 after treatment r=-.66, p<.0001, amplitude P3 after treatment r=.33, p<.04, omission error rate before 
treatment r=-.82, p<.0001 and omission error rate after treatment r=.51, p<.001 (for the group of ADHD children 
with treatment significant correlations were found between age and latency N1 before treatment rs=-.76, p<.001, 
amplitude N1 before treatment rs=.85, p<.0001, latency N1 after treatment rs=-.75, p<.001, amplitude N1 after 
treatment rs=.86, p<.0001, latency P3 before treatment rs=-.84, p<.0001, amplitude P3 before treatment rs=.69, 
p<.003, latency P3 after treatment rs=-.65, p<.006, amplitude P3 after treatment rs=.63, p<.009, omission error rate
before treatment rs=-.72, p<.002 and omission error rate after treatment rs=-.69, p<.003; for the group of ADHD 
children without treatment significant correlations were found between age and latency N1 before treatment rs=-.89, 
p<.0001, amplitude N1 before treatment rs=.41, p<.05, latency N1 after treatment rs=-.89, p<.0001, amplitude N1
after treatment rs=.48, p<.022, latency P3 before treatment rs=-.75, p<.0001, latency P3 after treatment rs=-.65, 
p<.001, omission error rate before treatment rs=-.86, p<.0001 and omission error rate after treatment rs=-.71, 
p<.0001). 
The high significant correlations were found between the latency N1 before treatment and amplitude N1
before treatment r=-.61, p<.0001, latency N1 after treatment r=-.98, p<.0001, amplitude N1 after treatment r=-.65, 
p<.0001, latency P3 before treatment r=.75, p<.0001, amplitude P3 before treatment r=-.45, p<.004, latency P3 after 
treatment r=.67, p<.0001, omission error rate before treatment r=.72, p<.0001, omission error rate after treatment
r=.46, p<.003 and correlation for amplitude P3 after treatment was significant at one tail r=-.31, p<.052 (for the 
group of ADHD children with treatment significant correlations were found between the latency N1 before 
treatment and amplitude N1 before treatment rs=-.79, p<.0001, latency N1 after treatment rs=.94, p<.0001, 
amplitude N1 after treatment rs=-.78, p<.0001, latency P3 before treatment rs=.82, p<.0001, amplitude P3 before 
treatment rs=-.60, p<.013, latency P3 after treatment rs=.65, p<.007, amplitude P3 after treatment rs=-.55, p<.027,
correlation for omission error rate after treatment was significant at one tail rs=.48, p<.059; for the group of ADHD 
children without treatment significant correlations were found between the latency N1 before treatment and 
amplitude N1 before treatment rs=-.57, p<.005, latency N1 after treatment rs=.98, p<.0001, amplitude N1 after 
treatment rs=-.63, p<.001, latency P3 before treatment rs=.85, p<.0001, latency P3 after treatment rs=.74, p<.0001, 
omission error rate after treatment rs=.76, p<.0001, omission error rate after treatment rs=.61, p<.002).
Table 2. Correlations of means of latency and amplitude (N1 and P3) before treatment for study groups.
latency N1
before treatment
amplitude N1
before 
treatment
latency N1
after 
treatment
amplitude N1
after treatment
latency P3
before 
treatment
amplitude P3
before 
treatment
latency P3
after 
treatment
amplitude P3
after 
treatment
omission error 
rates before 
treatment
omission error 
rates after 
treatment
latency N1
before 
treatment
Pearson 
Correlation
1.000 -.61(**) .98(**) -.65(**) .75(**) -.45(**) .67(**) -.31 .72(**) .46(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .004 .0001 .052 .0001 .003
Number of 
participants
39 39 39 39 39 39 39 39 39
amplitude 
N1 before 
treatment
Pearson 
Correlation
-.61(**) 1.000 -.63(**) .93(**) -.41(**) .60(**) -.45(**) .61(**) -.37(*) -.47(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .01 .0001 .004 .0001 .022 .003
Number of 
participants
39 39 39 39 39 39 39 39 39
latency N1
after 
treatment
Pearson 
Correlation
.98(**) -.63(**) 1.000 -.67(**) .73(**) -.40(*) .66(**) -.28 .72(**) .49(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .011 .0001 .08 .0001 .002
Number of 
participants
39 39 39 39 39 39 39 39 39
amplitude 
N1 after 
treatment
Pearson 
Correlation
-.65(**) .93(**) -.67(**) 1.000 -.45(**) .55(**) -.47(**) .57(**) -.41(**) -.44(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .004 .0001 .003 .0001 .01 .005
Number of 
participants
39 39 39 39 39 39 39 39 39
latency P3
before 
Pearson 
Correlation
.75(**) -.41(**) .73(**) -.45(**) 1.000 -.43(**) .91(**) -.20 .57(**) .22
treatment Sig. (2-
tailed)
.0001 .01 .0001 .004 .007 .0001 .214 .0001 .174
Number of 
participants
39 39 39 39 39 39 39 39 39
amplitude 
P3 before 
treatment
Pearson 
Correlation
-.45(**) .60(**) -.40(*) .55(**) -.43(**) 1.000 -.39(*) .77(**) -.34(*) -.28
Sig. (2-
tailed)
.004 .0001 .011 .0001 .007 .015 .0001 .035 .085
Number of 
participants
39 39 39 39 39 39 39 39 39
latency P3
after 
treatment
Pearson 
Correlation
.67(**) -.45(**) .66(**) -.47(**) .91(**) -.39(*) 1.000 -.32 .58(**) .36(*)
Sig. (2-
tailed)
.0001 .004 .0001 .003 .0001 .015 .051 .0001 .023
Number of 
participants
39 39 39 39 39 39 39 39 39
amplitude 
P3 after 
treatment
Pearson 
Correlation
-.31 .61(**) -.28 .57(**) -.20 .77(**) -.32 1.000 -.25 -.48(**)
Sig. (2-
tailed)
.052 .0001 .08 .0001 .214 .0001 .051 .129 .002
Number of 
participants
39 39 39 39 39 39 39 39 39
omission 
error rates 
before 
treatment
Pearson 
Correlation
.72(**) -.37(*) .72(**) -.41(**) .57(**) -.34(*) .58(**) -.25 1.000 .57(**)
Sig. (2-
tailed)
.0001 .022 .0001 .01 .0001 .035 .0001 .129 .0001
Number of 
participants
39 39 39 39 39 39 39 39 39
omission 
error rates 
after 
treatment
Pearson 
Correlation
.46(**) -.47(**) .49(**) -.44(**) .22 -.28 .36(*) -.48(**) .57(**) 1.000
Sig. (2-
tailed)
.003 .003 .002 .005 .174 .085 .023 .002 .0001
Number of 
participants
39 39 39 39 39 39 39 39 39
The high significant correlations were found between amplitude N1 before treatment and latency N1 after 
treatment r=-.63, p<.0001, amplitude N1 after treatment r=.93, p<.0001, latency P3 before treatment r=-.41, p<.01, 
amplitude P3 before treatment r=.60, p<.0001, latency P3 after treatment r=-.45, p<.004, amplitude P3 after 
treatment r=.61, p<.0001, omission error rate before treatment r=-.37, p<.022, omission error rate after treatment
r=-.47, p<.003 (for the group of ADHD children with treatment significant correlations were found between
amplitude N1 before treatment and latency N1 after treatment rs=-.84, p<.0001, amplitude N1 after treatment rs=.97, 
p<.0001, latency P3 before treatment rs=-.83, p<.0001, amplitude P3 before treatment rs=.76, p<.001, latency P3
after treatment rs=-.69, p<.003, amplitude P3 after treatment rs=.70, p<.002, omission error rate before treatment
rs=-.50, p<.026, omission error rate after treatment rs=-.77, p<.0001; for the group of ADHD children without 
treatment significant correlations were found between amplitude N1 before treatment and latency N1 after treatment 
rs=-.60, p<.002, amplitude N1 after treatment rs=.88, p<.0001, latency P3 before treatment rs=-.57, p<.005, latency 
P3 after treatment rs=-.48, p<.022, amplitude P3 after treatment rs=.42, p<.045, correlation for the amplitude P3
before treatment was significant at one tail rs=.37, p<.08).
The high significant correlations were found between latency N1 after treatment and amplitude N1 after 
treatment r=-.67, p<.0001, latency P3 before treatment r=.73, p<.0001, amplitude P3 before treatment r=-.40, 
p<.011, latency P3 after treatment r=.66, p<.0001, omission error rate before treatment r=.72, p<.0001, omission 
error rate after treatment r=.49, p<.002, correlation for the amplitude P3 after treatment was significant at one tail 
r=-.28, p<.08, (for the group of ADHD children with treatment significant correlations were found between latency 
N1 after treatment and amplitude N1 after treatment rs=-80, p<.0001, latency P3 before treatment rs=.81, p<.0001, 
amplitude P3 before treatment rs=-.62, p<.011, latency P3 after treatment rs=.67, p<.004, amplitude P3 after 
treatment rs=-.55, p<.028, correlations for the omission error rate before treatment rs=.44, p<.086 and omission 
error rate after treatment rs=.47, p<.064 were significant at one tail; for the group of ADHD children without 
treatment significant correlations were found between latency N1 after treatment and amplitude N1 after treatment 
rs=-.65, p<.001, latency P3 before treatment rs=.83, p<.0001, latency P3 after treatment rs=.70, p<.0001, omission
error rate before treatment rs=.76, p<.0001, omission error rate after treatment rs=.64, p<.001). 
The high significant correlations were found between the amplitude N1 after treatment and latency P3 before 
treatment r=-.45, p<.004, amplitude P3 before treatment r=.55, p<.0001, latency P3 after treatment r=-.47, p<.003,
amplitude P3 after treatment r=.57, p<.0001, omission error rate before treatment r=-.41, p<.01, omission error rate
after treatment r=-.44, p<.005 (for the group of ADHD children with treatment significant correlations were found 
between the amplitude N1 after treatment and latency P3 before treatment rs=-.77, p<.001, amplitude P3 before 
treatment rs=.64, p<.007, latency P3 after treatment rs=-.61, p<.012, amplitude P3 after treatment rs=.63, p<.01, 
omission error rate before treatment rs=-.52, p<.038, omission error rate after treatment rs=-.79, p<.0001; for the 
group of ADHD children without treatment significant correlations were found between the amplitude N1 after 
treatment and latency P3 before treatment rs=-.61, p<.002, amplitude P3 before treatment rs=.44, p<.034, latency P3
after treatment rs=-.56, p<.005, amplitude P3 after treatment rs=.53, p<.009 The correlation for the omission error 
rate before treatment was significant at one tail rs=-.37, p<.082). 
Table 3. Correlations of the mean age and means of latency and amplitude (N1 and P3) before treatment for the group of ADHD 
children with treatment.
latency N1
before 
treatment
amplitude 
N1 before 
treatment
latency N1
after 
treatment
amplitude 
N1 after 
treatment
latency P3
before 
treatment
amplitude 
P3 before 
treatment
latency P3
after 
treatment
amplitude 
P3 after 
treatment
omission 
error rates 
before 
treatment
omission 
error rates 
after 
treatment
latency N1
before 
treatment
Spearman's 
rho
1.000 -.79(**) .94(**) -.78(**) .82(**) -.60(*) .65(**) -.55(*) .39 .48
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .013 .007 .027 .140 .059
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
N1 before 
treatment
Spearman's 
rho
-.79(**) 1.000 -.84(**) .97(**) -.83(**) .76(**) -.69(**) .70(**) -.55(*) -.77(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .001 .003 .002 .026 .0001
Number of 
participants
16 16 16 16 16 16 16 16 16
latency N1
after 
treatment
Spearman's 
rho
.94(**) -.84(**) 1.000 -.80(**) .81(**) -.62(*) .67(**) -.55(*) .44 .47
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .011 .004 .028 .086 .064
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
N1 after 
treatment
Spearman's 
rho
-.78(**) .97(**) -.80(**) 1.000 -.77(**) .64(**) -.61(*) .63(**) -.52(*) -.79(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .001 .007 .012 .01 .038 .0001
Number of 
participants
16 16 16 16 16 16 16 16 16
latency P3
before 
Spearman's 
rho
.82(**) -.83(**) .81(**) -.77(**) 1.000 -.72(**) .87(**) -.62(**) .61(*) .49
treatment Sig. (2-
tailed)
.0001 .0001 .0001 .001 .002 .0001 .01 .013 .053
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
P3 before 
treatment
Spearman's 
rho
-.60(*) .76(**) -.62(*) .64(**) -.72(**) 1.000 -.66(**) .84(**) -.72(**) -.60(*)
Sig. (2-
tailed)
.013 .001 .011 .007 .002 .006 .0001 .002 .015
Number of 
participants
16 16 16 16 16 16 16 16 16
latency P3
after 
treatment
Spearman's 
rho
.65(**) -.69(**) .67(**) -.61(*) .87(**) -.66(**) 1.000 -.56(*) .50(*) .33
Sig. (2-
tailed)
.007 .003 .004 .012 .0001 .006 .025 .048 .211
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
P3 after 
treatment
Spearman's 
rho
-.55(*) .70(**) -.55(*) .63(**) -.62(**) .84(**) -.56(*) 1.000 -.50(*) -.60(*)
Sig. (2-
tailed)
.027 .002 .028 .01 .01 .0001 .025 .047 .014
Number of 
participants
16 16 16 16 16 16 16 16 16
omission 
error rates 
before 
treatment
Spearman's 
rho
.386 -.55(*) .44 -.52(*) .61(*) -.72(**) .50(*) -.50(*) 1.000 .47
Sig. (2-
tailed)
.140 .026 .086 .038 .013 .002 .048 .047 .068
Number of 
participants
16 16 16 16 16 16 16 16 16
omission 
error rates 
after 
treatment
Spearman's 
rho
.48 -.77(**) .47 -.79(**) .49 -.60(*) .33 -.60(*) .47 1.000
Sig. (2-
tailed)
.059 .0001 .064 .0001 .053 .015 .211 .014 .068
Number of 
participants
16 16 16 16 16 16 16 16 16
The high significant correlations were found between the latency P3 before treatment and amplitude P3 before 
treatment r=-.43, p<.007, latency P3 after treatment r=.91, p<.0001, omission error rate before treatment r=.57, 
p<.0001 (for the group of ADHD children with treatment significant correlations were found between the latency 
P3 before treatment and amplitude P3 before treatment rs=-.72, p<.002, latency P3 after treatment rs=.87, p<.0001,
amplitude P3 after treatment rs=-.62, p<.01, omission error rate before treatment rs=.61, p<.013. The correlation for 
the omission error rate after treatment was significant at one tail rs=.49, p<.053; for the group of ADHD children 
without treatment significant correlations were found between the latency P3 before treatment and amplitude P3
before treatment rs=-.44, p<.038, latency P3 after treatment rs=.90, p<.0001, omission error rate before treatment
rs=.59, p<.003, omission error rate after treatment rs=.52, p<.01. The correlation for the amplitude P3 after 
treatment was significant at one tail rs=-.37, p<.081).
The high significant correlations were found between the amplitude P3 before treatment and latency P3 after 
treatment r=-.39, p<.015, amplitude P3 after treatment r=.77, p<.0001, omission error rate before treatment r=-.34, 
p<.035, correlation for the omission error rate after treatment was significant at one tail r=-.28, p<.085 (for the 
group of ADHD children with treatment significant correlations were found between amplitude P3 before treatment 
and latency P3 after treatment rs=-.66, p<.006, amplitude P3 after treatment rs=.84, p<.0001, omission error rate
before treatment rs=-.72, p<.002, omission error rate after treatment rs=-.60, p<.015. The correlation for the 
omission error rate after treatment was significant at one tail rs=.49, p<.053; for the group of ADHD children 
without treatment significant correlations were found between the amplitude P3 before treatment and amplitude P3
after treatment rs=.91, p<.0001).
The high significant correlations were found between the latency P3 after treatment and omission error rate
before treatment r=.58, p<.0001, omission error rate after treatment r=.36, p<.023, correlation for the amplitude P3
after treatment was significant at one tail r=-.32, p<.051, (for the group of ADHD children with treatment 
significant correlations were found between the latency P3 after treatment and amplitude P3 after treatment rs=-.56, 
p<.025, omission error rate before treatment rs=.50, p<.048; for the group of ADHD children without treatment 
significant correlations were found between the latency P3 after treatment and, omission error rate before treatment
rs=.58, p<.004, omission error rate after treatment rs=.46, p<.026, correlation for the amplitude P3 after treatment
was significant at one tail rs=-.36, p<.093).
The high significant correlations were found between the amplitude P3 after treatment and omission error rate
after treatment r=-.48, p<.002 (for the group of ADHD children with treatment significant correlations were found 
between the amplitude P3 after treatment and omission error rate after treatment rs=-.50, p<.047 correlation for the 
amplitude P3 after treatment was significant at one tail rs=-.60, p<.014; for the group of ADHD children without 
treatment correlation analysis didn’t reveal significant correlations between the amplitude P3 after treatment and
omission error rates).
The high significant correlations were found between the omission error rate before treatment and omission 
error rate after treatment r=-.57, p<.0001 (for the group of ADHD children with treatment correlations between
omission error rates was significant at one tail rs=.47, p<.068; for the group of ADHD children without treatment 
correlation for omission error rates was rs=.78, p<.0001).
Table 4. Correlations of the mean age and means of latency and amplitude (N1 and P3) before treatment for the group of ADHD 
children without treatment.
latency N1
before 
treatment
amplitude 
N1 before 
treatment
latency N1
after 
treatment
amplitude 
N1 after 
treatment
latency P3
before 
treatment
amplitude 
P3 before 
treatment
latency P3
after 
treatment
amplitude 
P3 after 
treatment
omission 
error rates 
before 
treatment
omission 
error rates 
after 
treatment
latency N1
before 
treatment
Spearman's 
rho
1.000 -.79(**) .94(**) -.78(**) .82(**) -.60(*) .65(**) -.55(*) .39 .48
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .013 .007 .027 .140 .059
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
N1 before 
treatment
Spearman's 
rho
-.79(**) 1.000 -.84(**) .97(**) -.83(**) .76(**) -.69(**) .70(**) -.55(*) -.77(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .001 .003 .002 .026 .0001
Number of 
participants
16 16 16 16 16 16 16 16 16
latency N1
after 
treatment
Spearman's 
rho
.94(**) -.84(**) 1.000 -.80(**) .81(**) -.62(*) .67(**) -.55(*) .44 .47
Sig. (2-
tailed)
.0001 .0001 .0001 .0001 .011 .004 .028 .086 .064
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
N1 after 
treatment
Spearman's 
rho
-.78(**) .97(**) -.80(**) 1.000 -.77(**) .64(**) -.61(*) .63(**) -.52(*) -.79(**)
Sig. (2-
tailed)
.0001 .0001 .0001 .001 .007 .012 .01 .038 .0001
Number of 
participants
16 16 16 16 16 16 16 16 16
latency P3
before 
treatment
Spearman's 
rho
.82(**) -.83(**) .81(**) -.77(**) 1.000 -.72(**) .87(**) -.62(**) .61(*) .49
Sig. (2-
tailed)
.0001 .0001 .0001 .001 .002 .0001 .01 .013 .053
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
P3 before 
treatment
Spearman's 
rho
-.60(*) .76(**) -.62(*) .64(**) -.72(**) 1.000 -.66(**) .84(**) -.72(**) -.60(*)
Sig. (2-
tailed)
.013 .001 .011 .007 .002 .006 .0001 .002 .015
Number of 
participants
16 16 16 16 16 16 16 16 16
latency P3
after 
treatment
Spearman's 
rho
.65(**) -.69(**) .67(**) -.61(*) .87(**) -.66(**) 1.000 -.56(*) .50(*) .33
Sig. (2-
tailed)
.007 .003 .004 .012 .0001 .006 .025 .048 .211
Number of 
participants
16 16 16 16 16 16 16 16 16
amplitude 
P3 after 
treatment
Spearman's 
rho
-.55(*) .70(**) -.55(*) .63(**) -.62(**) .84(**) -.56(*) 1.000 -.50(*) -.60(*)
Sig. (2-
tailed)
.027 .002 .028 .01 .01 .0001 .025 .047 .014
Number of 
participants
16 16 16 16 16 16 16 16 16
omission 
error rates 
before 
treatment
Spearman's 
rho
.386 -.55(*) .44 -.52(*) .61(*) -.72(**) .50(*) -.50(*) 1.000 .47
Sig. (2-
tailed)
.140 .026 .086 .038 .013 .002 .048 .047 .068
Number of 
participants
16 16 16 16 16 16 16 16 16
omission 
error rates 
after 
treatment
Spearman's 
rho
.48 -.77(**) .47 -.79(**) .49 -.60(*) .33 -.60(*) .47 1.000
Sig. (2-
tailed)
.059 .0001 .064 .0001 .053 .015 .211 .014 .068
Number of 
participants
16 16 16 16 16 16 16 16 16
The high significant correlations were found between the latency P3 before treatment and amplitude P3 before 
treatment r=-.43, p<.007, latency P3 after treatment r=.91, p<.0001, omission error rate before treatment r=.57, 
p<.0001 (for the group of ADHD children with treatment significant correlations were found between the latency 
P3 before treatment and amplitude P3 before treatment rs=-.72, p<.002, latency P3 after treatment rs=.87, p<.0001,
amplitude P3 after treatment rs=-.62, p<.01, omission error rate before treatment rs=.61, p<.013. The correlation for 
the omission error rate after treatment was significant at one tail rs=.49, p<.053; for the group of ADHD children 
without treatment significant correlations were found between the latency P3 before treatment and amplitude P3
before treatment rs=-.44, p<.038, latency P3 after treatment rs=.90, p<.0001, omission error rate before treatment
rs=.59, p<.003, omission error rate after treatment rs=.52, p<.01. The correlation for the amplitude P3 after 
treatment was significant at one tail rs=-.37, p<.081).
The high significant correlations were found between the amplitude P3 before treatment and latency P3 after 
treatment r=-.39, p<.015, amplitude P3 after treatment r=.77, p<.0001, omission error rate before treatment r=-.34, 
p<.035, correlation for the omission error rate after treatment was significant at one tail r=-.28, p<.085 (for the 
group of ADHD children with treatment significant correlations were found between amplitude P3 before treatment 
and latency P3 after treatment rs=-.66, p<.006, amplitude P3 after treatment rs=.84, p<.0001, omission error rate
before treatment rs=-.72, p<.002, omission error rate after treatment rs=-.60, p<.015. The correlation for the 
omission error rate after treatment was significant at one tail rs=.49, p<.053; for the group of ADHD children 
without treatment significant correlations were found between the amplitude P3 before treatment and amplitude P3
after treatment rs=.91, p<.0001).
The high significant correlations were found between the latency P3 after treatment and omission error rate
before treatment r=.58, p<.0001, omission error rate after treatment r=.36, p<.023, correlation for the amplitude P3
after treatment was significant at one tail r=-.32, p<.051, (for the group of ADHD children with treatment 
significant correlations were found between the latency P3 after treatment and amplitude P3 after treatment rs=-.56, 
p<.025, omission error rate before treatment rs=.50, p<.048; for the group of ADHD children without treatment 
significant correlations were found between the latency P3 after treatment and, omission error rate before treatment
rs=.58, p<.004, omission error rate after treatment rs=.46, p<.026, correlation for the amplitude P3 after treatment
was significant at one tail rs=-.36, p<.093).
The high significant correlations were found between the amplitude P3 after treatment and omission error rate
after treatment r=-.48, p<.002 (for the group of ADHD children with treatment significant correlations were found 
between the amplitude P3 after treatment and omission error rate after treatment rs=-.50, p<.047 correlation for the 
amplitude P3 after treatment was significant at one tail rs=-.60, p<.014; for the group of ADHD children without 
treatment correlation analysis didn’t reveal significant correlations between the amplitude P3 after treatment and
omission error rates).
The high significant correlations were found between the omission error rate before treatment and omission 
error rate after treatment r=-.57, p<.0001 (for the group of ADHD children with treatment correlations between
omission error rates was significant at one tail rs=.47, p<.068; for the group of ADHD children without treatment 
correlation for omission error rates was rs=.78, p<.0001).
Table 4. Correlations of the mean age and means of latency and amplitude (N1 and P3) before treatment for the group of ADHD 
children without treatment.
latency N1
before 
treatment
amplitude 
N1 before 
treatment
latency N1
after 
treatment
amplitude 
N1 after 
treatment
latency P3
before 
treatment
amplitude 
P3 before 
treatment
latency P3
after 
treatment
amplitude 
P3 after 
treatment
omission 
error rates 
before 
treatment
omission 
error rates 
after 
treatment
latency N1
before 
treatment
Spearman's 
rho
1.000 -.57(**) .98(**) -.63(**) .85(**) -.33 .74(**) -.25 .76(**) .61(**)
Sig. (2-
tailed)
.005 .0001 .001 .0001 .122 .0001 .243 .0001 .002
Number of 
participants
23 23 23 23 23 23 23 23 23
amplitude 
N1 before 
treatment
Spearman's 
rho
-.57(**) 1.000 -.60(**) .88(**) -.57(**) .37 -.48(*) .42(*) -.29 -.23
Sig. (2-
tailed)
.005 .002 .0001 .005 .080 .022 .045 .182 .303
Number of 
participants
23 23 23 23 23 23 23 23 23
latency N1
after 
treatment
Spearman's 
rho
.98(**) -.60(**) 1.000 -.65(**) .83(**) -.30 .70(**) -.23 .76(**) .64(**)
Sig. (2-
tailed)
.0001 .002 .001 .0001 .171 .0001 .288 .0001 .001
Number of 
participants
23 23 23 23 23 23 23 23 23
amplitude 
N1 after 
treatment
Spearman's 
rho
-.63(**) .88(**) -.65(**) 1.000 -.61(**) .44(*) -.56(**) .53(**) -.37 -.27
Sig. (2-
tailed)
.001 .0001 .001 .002 .034 .005 .009 .082 .220
Number of 
participants
23 23 23 23 23 23 23 23 23
latency P3
before 
Spearman's 
rho
.85(**) -.57(**) .83(**) -.61(**) 1.000 -.44(*) .90(**) -.37 .59(**) .52(*)
treatment Sig. (2-
tailed)
.0001 .005 .000 .002 .038 .0001 .081 .003 .011
Number of 
participants
23 23 23 23 23 23 23 23 23
amplitude 
P3 before 
treatment
Spearman's 
rho
-.33 .37 -.30 .44(*) -.44(*) 1.000 -.35 .91(**) -.21 -.23
Sig. (2-
tailed)
.122 .080 .171 .034 .038 .107 .0001 .328 .283
Number of 
participants
23 23 23 23 23 23 23 23 23
latency P3
after 
treatment
Spearman's 
rho
.74(**) -.48(*) .70(**) -.56(**) .90(**) -.35 1.000 -.36 .58(**) .46(*)
Sig. (2-
tailed)
.0001 .022 .0001 .005 .0001 .107 .093 .004 .026
Number of 
participants
23 23 23 23 23 23 23 23 23
amplitude 
P3 after 
treatment
Spearman's 
rho
-.25 .42(*) -.23 .53(**) -.37 .91(**) -.36 1.000 -.14 -.16
Sig. (2-
tailed)
.243 .045 .288 .009 .081 .0001 .093 .515 .475
Number of 
participants
23 23 23 23 23 23 23 23 23
omission 
error rates 
before 
treatment
Spearman's 
rho
.76(**) -.29 .76(**) -.37 .59(**) -.21 .58(**) -.14 1.000 .78(**)
Sig. (2-
tailed)
.0001 .182 .0001 .082 .003 .328 .004 .515 .0001
Number of 
participants
23 23 23 23 23 23 23 23 23
omission 
error rates 
after 
treatment
Spearman's 
rho
.61(**) -.23 .64(**) -.27 .52(*) -.23 .46(*) -.16 .78(**) 1.000
Sig. (2-
tailed)
.002 .303 .001 .220 .011 .283 .026 .475 .0001
Number of 
participants
23 23 23 23 23 23 233 23 23
Discussion: As we explained above N1 reflects the simple process of recognition of stimuli. Our study replicate the 
position of Barry[18] and Oades  [32]  who confirmed  that   N1 latency on target stimuli showed tendency to be smaller in 
ADHD than controls during oddball task. According to our results it was obvious that NF does not affect on N1 
parameters. Thus it means that NF serving the improvement of attention parameters can not change the auditory 
information recognition process in the brain. As for later response like P3 as it was mentioned in the results that the 
mean amplitude P3 after treatment was significantly higher (p<.0001) for the ADHD treated group (mean=9.81, 
SD=1.87) compared to the ADHD non treated group (mean=7.3, SD=1.69).  As for latency it was described  that 
mean latency after treatment showed a significant effects of condition  (p<.0001) represents a large effect size and 
of interaction between group and condition ( p<.0001).  
Our study confirms once more the facts that in ADHD children younger than 12 years of age the amplitude of P3 
on target stimuli is reduced compared to controls [33]  but latency is increased [34], [35].  But the most important 
finding of our study was that NF training causes significant increase of amplitude and decrease of latency of P3. 
This point is very important as we mentioned above P3 amplitude  reflects effortfulness of the stimulus response 
and the intensity of processing  whereas P3 latency is taken as a reflection of the speed of information processing. 
Thus decreasing of effortfulness of mental activity and improvement of speed of information processing is one of 
the most significant domain of activity in ADHD children.  Modification of its component is extremely important 
in ADHD children as it is known that dysfunctions in cortical as well as subcortical structures plays the key role in 
the pathogenesis of ADHD [36].  As for psychological point of view the disorder of selection of adequate action is 
frequently expressed in ADHD population thus causing the impairment of executive attention. The effectiveness of 
NF on P3 can be explained by the following fact.  It is known that NF influences neural networks that support 
attention, executive functions and motor regulation. According to Makris and colleagues  [37] this complex network 
consists of several parallel networks: cortico-striatal, cortico-pallidal and cortico-cerebellar. The effectiveness of NF in the 
change of P3 parameters can be explained by the fact that structures functioning of which is changed during NF treatment 
participate in the electrogenesis of P3.
1. The role of prefrontal cortex in the pathogenesis of ADHD is evidence based [38]. It was suggested that during the 
occurrence of P3 the prefrontal cortex temporarily inhibits the mesencephalic activating system [39]. According to 
Knight the cessation of this inhibition, following the lesion of the prefrontal area could account for the P3 changes [ 
40]  detected in our study.  Thus it can be marker of functioning of prefrontal areas which are extremely important in 
the pathogenesis of ADHD.
2. The role of parietal lobes in the pathogenesis of ADHD is confirmed by Makris and collegues [ 41]. According to 
Simson [42] although existence of a frontal P3 generator could not be excluded, the generator of the P3 could most 
likely be localized to the inferior parietal lobe. Knight detected that [43] upper part of the parietal lobe does not play 
significant role in the genesis of the auditory P3 component. On the other hand, the auditory association 
cortical areas at the junction of the temporo-parietal lobes seem to be very important. The anatomical 
connections of this area with the prefrontal cortex may be significant as it is most important part of ADHD 
pathogenesis.Temporal lobe and parts of limbic system are also considered as generators of P3. Halgren 
and colleagues  [44] recorded auditory ERP from the amygdala, hippocampus and vertex using oddball 
paradigm. The author detecting  large amplitude components from these structures suggested  that they can 
be considered as generators of P3. The role of the hippocampus and amygdala in attention-processing has 
been elucidated by various clinical studies. According to Plessen and colleagues   [45] connectivity of the 
prefrontal regions with the hippocampus and amygdala regulates a variety of attentional, memory and 
emotional processes implicated in the pathophysiology of ADHD. The same authors detected larger 
hippocampal volumes in ADHD children and reported that, among children with hippocampal dysfunction, 
larger volumes tended to accompany less severe ADHD symptoms. The significance of hippocampus in NF 
effectiveness is huge as it is proved that frontal midline theta rhythm in human EEG is often associated with 
hippocampal theta activity. As it is obvious  that Papez circle structures like hippocampus, mammilary body  of 
hypothalamus and anterior nucleus of thalamus all together generate theta rhythm which was the basis of attention 
training during NF therapy [10].  The role of temporal lobes in P3 generation was described by various authors. 
According to Knight [46] after unilateral temporal lobe lesion (involving area 22, area 40, and the lower part of area 
39) the P3 disappear. Daruna and colleagues found that [47] in epileptic patients following unilateral temporal 
lobectomy the amplitude of the recorded P3 was smaller over the affected side.
3. As for basal ganglias their role in the generation of P3 was explained by Yingling [48] and Kropotov [49], [50] 
where striatum, globus pallidus, the ventro-lateral nucleus of the thalamus and adjacent areas were considered as a 
possible generators of P300 together with cortex. The fact that basal ganglia play the important role in the 
pathogenesis of ADHD is obvious. A growing number of neuroimaging studies have demonstrated smaller size of 
nucleus caudatus [51] and globus pallidus [52], [53]  in ADHD children.  Lubar [ 54] suggested that during NF 
therapy  the basis of which is EEG activity generated by thalamus the thalamic pacemaker generates different brain 
rhythms depending on which cortical loops they activate but changes in cortical loops can modify the firing rate of 
thalamic pacemakers and hence alter their firing pattern which is the basis of NF training used in our study. Thus 
thalamus together with other subcortical plays the key role in ADHD.
         Another important finding of our study was improvement is the rate of omission and commission errors which as we 
mentioned above are thought to be the index of impulsivity which together with inattentiveness is the most prominent feature 
of ADHD .  The mean omission errors rate after treatment was significantly higher (p<.0001) for the ADHD non 
treated group (mean=4.7, SD=1.79) compared to the ADHD treated group (mean=2.38, SD=.89). The mean 
commission errors rate after treatment was significantly higher  (p<.0001) for the ADHD non treated group 
(mean=4.87, SD=2.91) compared to the ADHD treated group (mean=.88, SD=.89). The same results were 
obtained for these variables using the nonparametric Mann Whitney U test. Impulsivity in ADHD children is caused 
by hypofunction of the dopaminergic pathways   especially those projected in fronto-striatal structures.
As we have observed the high significant correlations between age and latency N1 as well as between age and 
latency of P3 we have concluded that  ERPs are in correlation with age: the smaller child has longer latency and opposite. 
This detection is very important as earlier start of  NF treatment in children will be more effective and helps to avoid the 
problems accompanying ADHD in adolescence. Thus it means that NF directed to improvement of attention parameters does 
not affect simple auditory information processing in the human brain when significantly changes the functioning of the 
executive system reflected in the late ERP components connected to attention processes and selection of action which is very 
important part of executive functioning. 
In spite of several successful findings our work need further confirmation as the follow-up study is needed to observe 
how consistent is improvement of P3 parameters and how long it persists. Besides it will be very interesting to identify the 
profile of P3 parameters in various subtypes of ADHD and level of effectiveness of NF in these subtypes of children. 
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